You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dopamine Transporter

Showing 26 - 50 of 1,368
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early Longitudinal Imaging in Parkinson's Progression Markers

Recruiting
  • Parkinson Disease
    • New Haven, Connecticut
    • +2 more
    Jun 1, 2022

    Mental Disorders: Application of a Multi-modal & Domains System

    Not yet recruiting
    • Mental Disorder
      • Shanghai, Shanghai, China
        Shanghai Mental Health Center
      Jul 2, 2023

      Disclosing Imaging Study Information to Trial Participants

      Completed
      • Parkinsonian Syndrome
      • Parkinson
      • A series of questionnaires
      • New Haven, Connecticut
        Institute for Neurodegenerative Disorders
      Apr 1, 2019

      REM Sleep Behavior Disorder, Pre-motor Parkinson Disease, Symptomatic Parkinson Disease Trial in Los Angeles (Carvedilol)

      Enrolling by invitation
      • REM Sleep Behavior Disorder
      • +2 more
      • Los Angeles, California
        Cedars Sinai Medical Center
      Jul 26, 2021

      Multiple System Atrophy Trial in France (MRI acquisition, DAT-SPECT, blood sample, cerebrospinal fluid (optional))

      Active, not recruiting
      • Multiple System Atrophy
      • MRI acquisition
      • +4 more
      • Bordeaux, France
      • +9 more
      Oct 11, 2021

      Treatment Resistant Depression Trial in Louisville (Discontinuation of serotonergic antidepressants, Continuation of

      Recruiting
      • Treatment Resistant Depression
      • Discontinuation of serotonergic antidepressants
      • Continuation of serotonergic medications
      • Louisville, Kentucky
        University of Louisville, Department of Psychiatry and Behaviora
      May 21, 2022

      Pathophysiology of Gilles de la Tourette Syndrome. Part 1:

      Not yet recruiting
      • Gilles de la Tourette Syndrome
      • Tourette Syndrome
      • PET/MR scanner
      • Leipzig, Germany
        Max Planck Institute for Human Cognitive and Brain Sciences
      Feb 11, 2022

      Presynaptic Imaging in Major Depressive Episodes After COVID-19

      Recruiting
      • Long COVID
      • +2 more
      • [11C]DTBZ PET scan
      • +2 more
      • Toronto, Ontario, Canada
        Centre for Addiction and Mental Health
      Oct 15, 2023

      Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T

      Recruiting
      • Gilles de la Tourette Syndrome
      • Tourette Syndrome
      • MRI scanner (7 Tesla)
      • Leipzig, Germany
        Max Planck Institute for Human Cognitive and Brain Sciences
      Feb 10, 2022

      Parkinson's Disease Trial in Shanghai (hAESCs treatment, (saline))

      Not yet recruiting
      • Parkinson's Disease
      • hAESCs treatment
      • placebo (saline)
      • Shanghai, Shanghai, China
        Jingwen Wu
      Jun 23, 2022

      Glioma Trial in Oxford (Fluorodopa PET tracer)

      Recruiting
      • Glioma
      • Fluorodopa PET tracer
      • Oxford, Oxfordshire, United Kingdom
        Oxford University Hospitals NHS Foundation Trust
      Jul 28, 2022

      Pheochromocytoma, Endocrine Disease, Endocrine Diseases Trial run by the Eunice Kennedy Shriver National Institute of Child

      Recruiting
      • Pheochromocytoma
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 18, 2023

      Parkinson Disease Trial in Leuven (11C-UCB-J PET-CT, 18F-PE2I PET-MR)

      Completed
      • Parkinson Disease
      • 11C-UCB-J PET-CT
      • 18F-PE2I PET-MR
      • Leuven, Vlaams-Brabant, Belgium
        UZ Leuven
      May 18, 2022

      Parkinson's Disease Trial in Irvine, San Francisco, Columbus (AAV2-GDNF)

      Recruiting
      • Parkinson's Disease
      • AAV2-GDNF
      • Irvine, California
      • +2 more
      Feb 8, 2022

      Dopaminergic Transporter Density (DAT) in Obese Women

      Recruiting
      • Obesity
      • SPECT TRODAT-1
      • Ribeirão Preto, São Paulo, Brazil
        Clinical Hospital of Ribeirão Preto Medical School
      Mar 23, 2021

      Amyloidopathy, Choinopathy, Dopamine Responsiveness and Freezing

      Completed
      • Parkinson's Disease
      • Detailed motor testing, including FoG, in PD subjects
      • Ann Arbor, Michigan
        VA Ann Arbor Healthcare System, Ann Arbor, MI
      Jun 21, 2021

      Diabetes, Obesity Trial in Nashville (Detemir)

      Active, not recruiting
      • Diabetes
      • Obesity
      • Nashville, Tennessee
        Vanderbilt University
      Sep 7, 2021

      Parkinson Disease Trial in New Haven ([123I]ß-CIT and SPECT imaging, [123I]ß-CIT)

      Active, not recruiting
      • Parkinson Disease
      • New Haven, Connecticut
        Institute for Neurodegenerative Disorders
      Mar 28, 2022

      Early-stage Parkinson's Disease Trial in Worldwide (UCB0599, Placebo)

      Recruiting
      • Early-stage Parkinson's Disease
      • Birmingham, Alabama
      • +97 more
      Aug 18, 2022

      A Diagnostic Test for Dementia With Lewy Bodies

      Not yet recruiting
      • MCI-AD
      • MCI-DLB
      • Syn-One Test
      • (no location specified)
      Jul 26, 2022

      Symptomatic Parkinson Disease, REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease Trial in Los Angeles (Terazosin

      Recruiting
      • Symptomatic Parkinson Disease
      • +2 more
      • Terazosin therapy
      • Los Angeles, California
        Cedars Sinai Medical Center
      Aug 23, 2022

      Parkinson's Disease, Healthy Controls Group - Age and Sex-matched Trial in Grenoble (procedure, behavioral, other)

      Terminated
      • Parkinson's Disease
      • Healthy Controls Group - Age and Sex-matched
      • Brain MRI
      • +3 more
      • Grenoble, France
        CHU Grenoble Alpes
      May 6, 2022

      Parkinson's Disease, Drug-induced Parkinsonism Trial in Philadelphia (Exercise)

      Active, not recruiting
      • Parkinson's Disease
      • Drug-induced Parkinsonism
      • Exercise
      • Philadelphia, Pennsylvania
        Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
      Apr 8, 2021

      Healthy Trial in Basel (MDMA 120 mg + MDMA 60 mg, MDMA 120 mg + , Placebo)

      Not yet recruiting
      • Healthy
      • MDMA 120 mg + MDMA 60 mg
      • +2 more
      • Basel, Switzerland
        University Hospital
      Mar 28, 2023

      REM Sleep Behavior Disorder, Pre-motor Parkinson Disease, Symptomatic Parkinson Disease Trial in Los Angeles (Carvedilol)

      Recruiting
      • REM Sleep Behavior Disorder
      • +2 more
      • Los Angeles, California
        Cedars Sinai Medical Center
      Aug 23, 2022